Cardiff Lexington Corp (CDIX) stock
CDIXOTCServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
$0.04−0.01 (-25.53%)
Close on Oct 19, 2026Market cap $550.31KP/E –Yield –
Cardiff Lexington operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Cardiff Lexington's operating cash flow for the twelve months ending Sep 30, 2026 was -$625.95K. For fiscal 2025 it was -$2.85M. The highest annual figure on record is -$75.77K in fiscal 2015.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.85M | – |
| FY2024 | Dec 31, 2024 | -$2.77M | – |
| FY2023 | Dec 31, 2023 | -$1.81M | – |
| FY2022 | Dec 31, 2022 | -$1.15M | – |
| FY2021 | Dec 31, 2021 | -$850.14K | – |
| FY2020 | Dec 31, 2020 | -$903.42K | – |
| FY2019 | Dec 31, 2019 | -$159.46K | – |
| FY2018 | Dec 31, 2018 | -$1.10M | – |
| FY2017 | Dec 31, 2017 | -$614.90K | – |
| FY2016 | Dec 31, 2016 | -$198.14K | – |
| FY2015 | Dec 31, 2015 | -$75.77K | – |
| FY2014 | Dec 31, 2014 | -$696.73K | – |
| FY2013 | Dec 31, 2013 | -$204.93K | – |
| FY2012 | Dec 31, 2012 | -$255.82K | – |
| FY2011 | Dec 31, 2011 | -$300.72K | – |
| FY2010 | Dec 31, 2010 | -$196.14K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $432.67K | – |
| Q2 FY2026 | Jun 30, 2026 | -$651.92K | – |
| Q1 FY2026 | Mar 31, 2026 | -$16.73K | – |
| Q4 FY2025 | Dec 31, 2025 | -$389.97K | – |
| Q3 FY2025 | Sep 30, 2025 | -$574.30K | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.40M | – |
| Q1 FY2025 | Mar 31, 2025 | -$491.42K | – |
| Q4 FY2024 | Dec 31, 2024 | -$722.56K | – |
| Q3 FY2024 | Sep 30, 2024 | -$907.94K | – |
| Q2 FY2024 | Jun 30, 2024 | -$100.28K | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.04M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.25M | – |
| Q3 FY2023 | Sep 30, 2023 | -$297.08K | -607.3% |
| Q2 FY2023 | Jun 30, 2023 | -$99.48K | – |
| Q1 FY2023 | Mar 31, 2023 | -$160.99K | – |
| Q4 FY2022 | Dec 31, 2022 | -$736.06K | – |
| Q3 FY2022 | Sep 30, 2022 | $58.56K | -97.0% |
| Q2 FY2022 | Jun 30, 2022 | -$96.72K | – |
| Q1 FY2022 | Mar 31, 2022 | -$376.45K | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.20M | – |
| Q3 FY2021 | Sep 30, 2021 | $1.92M | – |
| Q2 FY2021 | Jun 30, 2021 | -$366.38K | – |
| Q1 FY2021 | Mar 31, 2021 | -$208.95K | – |
| Q4 FY2020 | Dec 31, 2020 | -$459.48K | -128.6% |
| Q3 FY2020 | Sep 30, 2020 | -$77.70K | – |
| Q2 FY2020 | Jun 30, 2020 | -$291.69K | -461.6% |
| Q1 FY2020 | Mar 31, 2020 | -$74.55K | – |
| Q4 FY2019 | Dec 31, 2019 | $1.61M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.73M | – |
| Q2 FY2019 | Jun 30, 2019 | $80.66K | – |
| Q1 FY2019 | Mar 31, 2019 | -$120.99K | – |
| Q4 FY2018 | Dec 31, 2018 | -$210.61K | – |
| Q3 FY2018 | Sep 30, 2018 | -$579.35K | – |
| Q2 FY2018 | Jun 30, 2018 | -$83.50K | – |
| Q1 FY2018 | Mar 31, 2018 | -$225.37K | – |
| Q4 FY2017 | Dec 31, 2017 | -$174.13K | – |
| Q3 FY2017 | Sep 30, 2017 | -$112.14K | – |
| Q2 FY2017 | Jun 30, 2017 | -$305.25K | – |
| Q1 FY2017 | Mar 31, 2017 | -$23.39K | – |
| Q4 FY2016 | Dec 31, 2016 | -$124.40K | – |
See a number that looks wrong?